30-Day Prescription Hair Spray 3 Treatment Program
The 30-Day Prescription Hair Spray 3 Treatment Program is designed for eligible adults seeking provider-guided care for certain forms of hair thinning or patterned hair loss through Newfield Health’s telehealth platform.
This compounded topical spray combines minoxidil, finasteride, caffeine, triamcinolone, and tretinoin in one prescription formulation. A licensed healthcare provider reviews your hair-loss pattern, health history, current medications, allergies, scalp condition, and other relevant factors before determining whether this treatment is appropriate.
Program Includes
- 30-day treatment program
- Compounded prescription topical spray
- Five active ingredients in one formulation
- Confidential online medical assessment
- Licensed healthcare provider evaluation
- Prescription transmitted to a licensed compounding pharmacy if approved
- Provider-guided treatment management and follow-up
Formula Details
- Minoxidil
- Finasteride
- Caffeine
- Triamcinolone
- Tretinoin
- Dosage Form: Topical Spray
- Supply Duration: 30 Days
How It Works
- Complete your confidential online hair-loss assessment.
- A licensed healthcare provider reviews your health information and hair-loss pattern.
- If treatment is clinically appropriate, a prescription is sent to a licensed compounding pharmacy.
- The pharmacy prepares the prescribed topical spray and ships it directly to your address.
Who May Be Considered
This program may be considered for eligible adults experiencing certain forms of patterned or progressive hair thinning. Because hair loss can have multiple causes, your provider may recommend additional evaluation when thyroid, hormonal, nutritional, inflammatory, autoimmune, or other contributing factors are suspected.
Important Safety Information
This prescription formulation is not appropriate for everyone. Your provider will review your medical history, medications, allergies, scalp health, pregnancy status, and other relevant clinical factors before prescribing treatment.
Potential reactions may include scalp irritation, redness, itching, dryness, flaking, unwanted hair growth outside the application area, dizziness, blood-pressure changes, sexual side effects, mood-related symptoms, or other ingredient-specific effects. Contact your healthcare provider if you experience persistent or concerning symptoms.
Finasteride should not be used during pregnancy. Patients who are pregnant, may become pregnant, or are breastfeeding should discuss exposure precautions and alternative treatment options with their healthcare provider.
Compounded Topical Finasteride Notice
This program uses a compounded topical formulation. There are currently no FDA-approved topical finasteride products. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.
A licensed healthcare provider determines whether this compounded formulation is appropriate based on your individual clinical needs.
Prescription Required
Purchasing or enrolling in this program does not guarantee that a prescription will be issued. Treatment eligibility and formulation selection are determined independently by a licensed healthcare provider following a complete clinical review.
